rs779896449
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_004453.4(ETFDH):c.413T>G(p.Leu138Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000033 in 1,544,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_004453.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETFDH | NM_004453.4 | c.413T>G | p.Leu138Arg | missense_variant | Exon 4 of 13 | ENST00000511912.6 | NP_004444.2 | |
ETFDH | NM_001281737.2 | c.272T>G | p.Leu91Arg | missense_variant | Exon 3 of 12 | NP_001268666.1 | ||
ETFDH | NM_001281738.1 | c.230T>G | p.Leu77Arg | missense_variant | Exon 2 of 11 | NP_001268667.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250696Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135604
GnomAD4 exome AF: 0.0000352 AC: 49AN: 1392256Hom.: 0 Cov.: 24 AF XY: 0.0000301 AC XY: 21AN XY: 696934
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
Multiple acyl-CoA dehydrogenase deficiency Pathogenic:4
Variant summary: ETFDH c.413T>G (p.Leu138Arg) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250696 control chromosomes (gnomAD). c.413T>G has been reported in the literature in individuals affected with Glutaric aciduria, type 2 (Goodman_2002, Olsen_2004, Cornelius_2012). These data indicate that the variant may be associated with disease. A functional study, Cornelius_2012, found the variant to impact enzyme activity and protein stability. Two ClinVar submissions (evaluation after 2014) cite the variant once as pathogenic and once as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 138 of the ETFDH protein (p.Leu138Arg). This variant is present in population databases (rs779896449, gnomAD 0.002%). This missense change has been observed in individuals with multiple acyl-CoA dehydrogenase (PMID: 12359134, 15669683, 32925727). ClinVar contains an entry for this variant (Variation ID: 431962). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ETFDH protein function. Experimental studies have shown that this missense change affects ETFDH function (PMID: 22611163). For these reasons, this variant has been classified as Pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
The L138R missense variant in the ETFDH gene has been reported previously in association with glutaric aciduria II (GAII) (Olsen et al. 2004; Cornelius et al. 2012; Goodman et al. 2002). Expression studies show that L138R profoundly reduces the amount and activity of the electron transfer flavoprotein-ubiquinone oxidoreductase enzyme with no significant response to increasing concentrations of riboflavin (Cornelius et al. 2012). The L138R variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The L138R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, we interpret L138R to be a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at